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ABSTRACT
Morvan syndrome is a rare disorder of peripheral nerve hyperexcitability, autonomic and central nervous system hyperactivity. It is 
considered autoimmune and paraneoplastic in nature. The most common associated antibodies are voltage-gated potassium channel 
(VGKC) complex antibodies which target leucine-rich glioma inactivated 1(LGI-1) and contactin-associated protein 2 (CASPR-2). 
It is characterized by myokymia, burning pain, cramps, stiffness, weakness, hyperhidrosis, weight loss, insomnia, and hallucinations. 
Thymectomy, long-term immunosuppression, plasmapheresis, intravenous immunoglobulin (IVIG), steroids are the treatment 
options. Carbamazepine, phenytoin, amitriptyline, and benzodiazepine are useful in relieving symptoms. We report a rare case of 
this disease from western Rajasthan who presented with bilateral diffuse burning pain, cramps, insomnia, weight loss, hyperhidrosis, 
visual hallucinations, and continuous muscle twitching and rippling activity over the lower back paraspinal muscles. His serum 
VGKC antibodies were positive. He was treated with IV methylprednisolone (MPS) and IVIG and had a good response to therapy. 
We should look for rippling muscle movement in a high index of suspicion and should not be missed.
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Morvan syndrome is a rare disease discovered in 1890 by Augustin Marie Morvan [1,2]. There have been approximately 60 cases published in the French 
and other literature but only a few in the English literature 
[3]. It is considered as a part of Neuromyotonia or syndrome 
of continuous muscle fiber activity. It is characterized by 
subacute onset muscle stiffness, continuous twitching, and 
quivering of muscles, cramps, anxiety, confusion, decreased 
sleep, hallucinations, excess sweating, memory disturbance, 
sense  of burning and weight loss. Distal muscles are more 
commonly involved in contrast to axial involvement as contrast 
to stiff-person syndrome. It is associated with voltage-gated 
potassium channel antibodies and paraneoplastic disorders. 
Systemic lupus erythematosus (SLE) association is also 
reported. Abnormal continuous muscle rippling movement 
is a clue to the diagnosis. Spontaneous remission was seen 
over time and around 10% of cases can lead to death [4]. 
Immunosuppression in the form of steroids, intravenous 
immunoglobulin (IVIG) and plasma exchange are the 
mainstay of therapy along with drugs like carbamazepine, 
phenytoin, amitriptyline and benzodiazepine which are useful 
in relieving symptoms.
We report this case considering the rarity of this disease 
and a very high index of suspicion is required to suspect such 
syndrome. Detail history along with a search for rippling muscle 
movement in the examination should be carefully looked for 
the diagnosis. 
CASE REPORT
A 34-year old male presented with a history of sub-acute onset 
progressive symptoms in the form of diffuse burning sensation 
in all the 4 limbs, myalgia, and cramps in legs, polyarthralgia, 
insomnia, weight loss, hyperhidrosis, agitation, anxiety, 
palpitation, visual hallucinations, constipation and backache for 
the last 5 months. No significant past and family history was 
present. There was no history of seizures, abnormal movement, 
headache, and memory loss. 
General examination suggested cachexia. Vitals were normal. 
His central nervous system examination was normal except 
continuous rippling muscle movement over the lower back and 
flanks (video 1). On the basis of his typical clinical features and 
myokymia, Morvan syndrome was suspected. 
His routine investigations including complete blood counts, 
biochemistry, electrolytes, erythrocyte sedimentation rate (ESR) 
and creatine phosphokinase (CPK-NAC) were normal. He was 
strongly positive for CASPR-2 and LGI-1 antibodies. His Magnetic 
resonance imaging (MRI) brain and spinal cord screening, 
Contrast-enhanced computed tomography (CECT) chest and 
abdomen were normal. The cerebrospinal fluid study was normal. 
His nerve conduction studies (NCV) and electroencephalogram 
(EEG) were unremarkable. Electromyography (EMG) was 
suggestive of rhythmic grouped repetitive doublets and triplets 
suggestive of myokymic discharges (Fig. 1).
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The patient was started on intravenous (IV) methylprednisolone 
1gm/day, phenytoin 300 mg/day, carbamazepine 600 mg/day, 
amitriptyline 50 mg/day and lorazepam 10 mg/day. After 5 days, 
IVIG (2gm/kg over 5 days) was added as the patient did not have 
a good response. After the 3rd cycle of IVIG (1gm/kg over 3 days, 
3 weeks apart), he responded nicely. In follow-up after 2 months 
of therapy, the patient got relieved with his all symptoms and his 
quivering over back muscles disappeared (video 2).
DISCUSSION
Morvan’s syndrome is a rare autoimmune or paraneoplastic 
disorder which manifests as peripheral nerve hyperexcitability 
with dysautonomic features, cognitive, behavioral 
abnormalities, insomnia and agrypnia excitation [5]. Male 
predominance has been seen in the reported cases [6]. The 
association of disease with thymoma, prostate adenoma, in-
situ carcinoma of the sigmoid colon, autoimmune diseases, 
and autoantibodies suggests autoimmune or paraneoplastic 
pathogenesis [7]. 
Association with some heavy metals like gold, mercury, or 
manganese poisoning has also been reported [8]. Association 
with SLE also described [9]. One study reported Morvan 
syndrome cases after scrotal sac drainage and chemical 
instillation in hydrocele [10]. Antibodies against voltage-gated 
potassium channels (VGKC), acetylcholine receptor antibody, 
titin, and N-type calcium channels have been described in the 
pathophysiology of this disease [5].
The affection of these antibodies to the hippocampus can 
also cause CNS dysfunction [5,6]. One case report from India 
reported extensive neurological manifestations affecting the 
peripheral nervous system in form of quivering of muscles, 
neuromyotonia, autonomic features in form of tachycardia, 
low blood pressure, increased sweating, bladder symptoms 
and central nervous system involvement in form of decreased 
sleep, altered behavior in sleep, generalized hyperreflexia [11]. 
Isaac’s syndrome also presents as continuous muscle fiber 
activity with myokymia, at rest muscle stiffness, cramps but 
additional above-mentioned features are found in Morvan’s 
syndrome apart from Issac’s syndrome [12]. Close differential 
diagnosis of Morvan’s syndrome includes limbic encephalitis, 
acquired neuromyotonia (Isaac syndrome), and fatal familial 
insomnia [1,3]. 
EEG, NCV, brain MRI and CSF findings are not much 
helpful in diagnosis and may have non-specific results. The 
electrophysiological hallmark is the spontaneous firing of single 
motor units as a doublet, triplet or multiplet discharges that have 
a high intra burst frequency (usually 150 to 300 Hz) suggestive 
of myokymia [13].
No common consensus and guidelines regarding treatment 
are available yet. Phenytoin, carbamazepine, amitriptyline, 
and benzodiazepine may be useful [5,14]. Immunosuppressive 
therapies, encompassing corticosteroids, IVIG, plasmapheresis, 
azathioprine, methotrexate and more recently, rituximab, are the 
mainstay of therapy [14]. A thymectomy is an option in thymoma 
associated cases. One Indian case report suggested that plasma 
exchange as a treatment modality should always be considered in 
the absence of established guidelines [15]. One more case report 
of a 48-year-old female with Morvan syndrome also reported 
from India [16]. 
In our case, on the basis of his typical clinical features and 
myokymia, we suspected Morvan syndrome. He was strongly 
positive for CASPR-2 and LGI-1 antibodies and EMG was also 
supportive. The patient was started on carbamazepine, phenytoin, 
amitriptyline, lorazepam,and steroids. IVIG was also added as the 
patient did not have a good response. After 3rd cycle of IVIG 3 
weeks apart, he responded nicely.
CONCLUSION
Morvan syndrome is a rare disease of autoimmune and 
paraneoplastic etiology. A detail examination should be 
done to look for rippling muscle movement in a high index 
of suspicion and should not be missed. As the awareness and 
knowledge are increasing about this rare disease more case 
reports are being published and guideline is yet to be made 
regarding treatment.
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